LINX Acid Reflux Implant Lawsuit | 2026 Latest Updates

People who received a LINX Reflux Management System implant for acid reflux are pursuing lawsuits. They say the device’s bead-and-wire ring broke or shifted inside the body, sometimes requiring surgery to remove or replace it. No class action or multidistrict litigation has formed. Instead, people are filing individual product-liability lawsuits against Torax Medical, Inc. and Ethicon, Inc. in federal court in Minnesota, with new cases arriving every few months. The newest case, filed June 26, 2026, joined dozens of similar claims dating back to 2023. A separate 2018 recall of the device closed in 2020 and is not an open case today.

Latest LINX Acid Reflux Implant Lawsuit Updates

June 26, 2026: Heath V. Torax Medical Is Filed

Heath v. Torax Medical, Inc. was filed in the U.S. District Court for the District of Minnesota, docket 0:26-cv-03112, against Torax Medical and Ethicon, Inc., over the LINX Reflux Management System [1]. The case is one of dozens of individual LINX suits. It follows the same defect theory: a bead-and-wire ring that can separate and require a second surgery to remove.

February 10, 2026: Wingett V. Torax Medical Is Filed

Wingett v. Torax Medical, Inc. was filed in the same Minnesota court, docket 0:26-cv-01290, months after the previous LINX filing. The complaint again names Torax Medical and Ethicon, Inc. as defendants. Wingett is suing individually, like the other plaintiffs, over a LINX Reflux Management System device that reportedly failed and required additional surgery, the same pattern described in the complaints filed before it.

May 5, 2025: Hashimoto V. Torax Medical Is Filed

Patient Randall Hashimoto filed suit against Torax Medical, Inc. and Ethicon, Inc., a Johnson & Johnson company, in federal docket 0:25-cv-01982, alleging his LINX device failed and required a second operation to remove. His case, like others filed since 2023, argues Torax Medical and Ethicon knew or should have known about the bead-and-wire defect years before Hashimoto’s implant surgery took place.

February 16, 2023: Noblet Files the First LINX Lawsuit

Noblet v. Torax Medical, Inc., docket 0:23-cv-00403, was the earliest RECAP-indexed product-liability suit over the LINX device. It was filed in the same Minnesota federal court as every case that followed it in the years since. More than a dozen similar lawsuits over the LINX Reflux Management System followed in the years since, each filed as its own individual case.

November 4, 2020: FDA Lists the LINX Recall as Terminated

The FDA updated its recall record for the LINX Reflux Management System to Terminated on November 4, 2020, closing the case it had opened two years earlier [2]. No new U.S. recall of the device has followed. The 2020 closure predates every lawsuit listed above, since those cases involve devices implanted years before the recall reached its formal end.

April 20, 2018: Torax Medical Recalls 9,131 LINX Devices

Torax Medical, Inc. told hospitals and physicians to quarantine and return LINX devices after identifying a wire-link separation defect that could leave a device open, a problem covering 9,131 devices worldwide. The recall covered specific bead configurations sold under Product Codes LXC and LXM. It did not cover every LINX device that had already been implanted worldwide up to that point.

What Is the LINX Reflux Management System?

The FDA-filed instructions for use describe the LINX Reflux Management System as titanium beads with magnetic cores. Independent titanium wires connect them into a ring that adds strength to a weak lower esophageal sphincter [3]. Surgeons implant the ring around the sphincter during a laparoscopic procedure. When a person swallows, the beads separate along the wire so food and liquid pass through, then close again to block stomach acid from flowing back up.

Who May Be Affected?

People whose LINX Reflux Management System device broke, disconnected, or migrated may be affected by this litigation. Many needed endoscopic dilation or surgery to remove or revise the device afterward. These circumstances match the 2018 recall record and the product-liability complaints already filed against Torax Medical and Ethicon. No multidistrict litigation has been created for LINX claims, according to the federal docket list that tracks these consolidations [4]. Each person’s case proceeds on its own, alongside dozens of similar product-liability filings already pending in the same Minnesota federal court. Whether a specific case fits this litigation, or a related recall, can only be confirmed through an individual legal review.

Reported Injuries or Damages

Complaints accuse Torax Medical and Ethicon of selling a LINX device whose bead-and-wire ring could separate or disconnect inside the body. That is the same failure mechanism the FDA cited in its 2018 recall, and fixing it can require a second surgery. Separately, a 2025 case-series study in Surgical Endoscopy reviewed 13 explanted LINX devices. Dysphagia and recurrent reflux, not device erosion, were the most common reasons patients needed the implant removed [5]. Reports of a device problem are not the same as legal proof. Each lawsuit still has to show the specific device that failed and that the failure caused the injury claimed.

Recall and Regulatory Background

Torax Medical, Inc.’s 2018 recall and its later closure are detailed above in the Latest LINX Acid Reflux Implant Lawsuit Updates. No other LINX recall or safety action is open in the United States today. A recall on its own does not prove a manufacturer is legally liable for an injury a specific device caused.

Evidence to Preserve

People who believe a LINX device failure caused their injury should keep the following records before starting a legal review. Older paperwork and images can be hard to replace later:

• The implant card or model and bead-count number given at the time of surgery
• Records of the original implant procedure and any later dilation, revision, or removal surgery
• Imaging or endoscopy reports showing the device’s position before and after any procedure
• Purchase, insurance, and billing records connected to the implant or a later surgery
• Correspondence with the surgeon, hospital, or the manufacturer about the device

Keeping these records together before a legal review makes it easier for a lawyer to match the specific device and dates to the pattern described in the lawsuits above.

Filing Deadlines

Deadlines for filing a LINX lawsuit come from state law rather than one federal rule. The time allowed depends on where the person lives and when the device failure happened. Some states start counting from the date of surgery. Others start from the date a doctor connected the symptoms to the device, so the diagnosis date can matter as much as the implant date. Missing a filing deadline can end a claim even when the facts are strong, so anyone considering a LINX lawsuit should talk to a lawyer promptly.

Potential Compensation

People pursuing a LINX lawsuit may seek damages tied to the medical costs of a revision or removal surgery and related follow-up care. They may also seek lost income during recovery and compensation for pain and suffering. No LINX verdict or settlement has been reported publicly, so no case has set a dollar figure for these claims. Compensation amounts vary by case. Past results do not guarantee future outcomes. A lawyer can review how these categories apply to potential compensation in a specific case.

Frequently Asked Questions

Has the LINX Acid Reflux Implant Been Recalled?

Yes, the LINX acid reflux implant recall is closed. The FDA tracked the 2018 recall under Recall Numbers Z-2038-2018 and Z-2041-2018 (Recall Event ID 79822), and that case is no longer open. No new U.S. recall has followed it.

Why Are Lawsuits Being Filed over the LINX Acid Reflux Implant?

Lawsuits are being filed over the LINX acid reflux implant because plaintiffs say the device’s bead-and-wire ring failed inside the body. Court dockets classify these filings as personal injury product liability actions, and plaintiffs seek damages for the surgery needed to remove a failed device.

What Does Research Say About LINX Device Failure Rates?

Research on LINX device failure rates comes from a 2025 case series in Surgical Endoscopy, which found published explant rates ranging from 0% to 12.6% of patients, with a median around 4.7%. More than 40,000 LINX devices have been implanted since 2012.

Which Countries Was the LINX Device Recalled In?

The LINX device was recalled in the United States and, according to Torax Medical’s 2018 recall notice, in Austria, France, Germany, Italy, Scotland, Spain, Switzerland, and the United Kingdom. The company mailed recall letters to U.S. facilities on April 20, 2018, and to facilities abroad three days later.

How Was the LINX Recall Carried Out?

The LINX recall was carried out by mail. Torax Medical sent hospitals and physicians an urgent field-safety notice. It asked them to quarantine and return any affected device, then confirm receipt with a Business Reply Form within three business days. Questions went to Torax Medical’s support line at 1-877-384-4266.

Who Is Torax Medical, Inc.?

Torax Medical, Inc. is the Shoreview, Minnesota company the FDA lists as the maker of the recalled device, under premarket approval number P100049. Its own web address now redirects to Johnson & Johnson MedTech, which continues to sell the device under the Ethicon business.

References

1. https://www.courtlistener.com/?q=%22Torax+Medical%22&type=r
2. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=163589
3. https://www.accessdata.fda.gov/cdrh_docs/pdf10/p100049c.pdf
4. https://www.jpml.uscourts.gov/pending-mdls-0
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC12287130/